Clinical Trials
11 trialsNCT07590024 2026-06-04
RAIRI-NPC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Recruiting
NCT07618078 2026-06-03
Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Recruiting
NCT05941741 2026-05-11
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Sun Yat-sen University
Phase 3 Recruiting
NCT07070479 2025-09-18
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
Sun Yat-sen University
Phase 2 Recruiting
NCT03984357 2025-07-17
PLATINUM
Sun Yat-sen University
Phase 2 Completed
NCT04907370 2025-07-16
DIAMOND
Sun Yat-sen University
Phase 3 Active not recruiting
NCT06472713 2025-01-13
Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC
Sun Yat-sen University
Phase 2 Recruiting
NCT05520814 2023-09-21
PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT05431764 2022-06-24
Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Recruiting
NCT05290194 2022-04-14
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2 Recruiting
NCT04769076 2021-02-25
The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown